Receptor-induced conformational changes of murine coronavirus spike protein

Journal of Virology

Volumn 76, Issue 23, 2002, Pages 11819-11826

  Matsuyama, Shutoku ^a   Taguchi, Fumihiro ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN S; PROTEINASE K; VIRUS RECEPTOR;

ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONFORMATIONAL TRANSITION; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; RECEPTOR BINDING; TEMPERATURE DEPENDENCE; VIRUS CELL INTERACTION; WESTERN BLOTTING;

ANIMALS; CELL LINE; CRICETINAE; ENDOPEPTIDASE K; MEMBRANE FUSION; MEMBRANE GLYCOPROTEINS; MICE; MURINE HEPATITIS VIRUS; MUTATION; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN SUBUNITS; RECEPTORS, VIRUS; SOLUBILITY; VIRAL ENVELOPE PROTEINS;

EID: 0036889416     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.23.11819-11826.2002     Document Type: Article

References (53)

1. Beauchemin, N., P. Draber, G. Dveksler, P. Gold, S. Gray-Owen, F. Grunert, S. Hammarstrom, K. V. Holmes, A. Karlsson, M. Kuroki, S. H. Lin, L. Lucka, S. M. Naijar, M. Neumaier, B. Obrink, J. E. Shively, K. M. Skubitz, C. P. Stanners, P. Thomas, J. A. Thompson, M. Virji, S. von Kleist, C. Wagener, S. Watt, and W. Zimmermann. 1999. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp. Cell Res. 252:243-249.
2. Bullough, P. A., F. M. Hughson, J. J. Skehel, and D. C. Wiley. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion Nature 371:37-43
3. Chen, D. C., D. Fass, J. M. Berger, and P. S. Kim. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89:263-273.
4. Chen, D. C., and P. S. Kim. 1998. HIV entry and its inhibition. Cell 93:681-684.
5. Chen, D. S., M. Asanaka, K. Yokomori, F. Wang, S. B. Hwang, H. Li, and M. M. C. Lai. 1995. A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc. Natl. Acad. Sci. USA 92:12095-12099.
6. Damico, R., and P. Bates. 2000. Soluble receptor-induced retroviral infection of receptor-deficient cells. J. Virol. 74:6469-6475.
7. Damico, R. L., J. Crane, and P. Bates. 1998. Receptor-triggered membrane association of a model retroviral glycoprotein. Proc. Natl. Acad. Sci. USA 95:2580-2585.
8. De Groot, R. J., W. Luytjes, M. C. Horzinek, B. A. M. van der Zeijst, W. J. M. Spaan, and J. A. Lenstra. 1987. Evidence for a coiled-coil structure in the spike of coronaviruses. J. Mol. Biol. 196:963-966.
9. Dveksler, G. S., A. A. Basile, C. B. Cardellichio, and K. V. Holmes. 1995. Mouse hepatitis virus receptor activities of an MHVR/mph chimera and MHVR mutants lacking N-linked glycosylation of the N-terminal domain. J. Virol. 69:543-546.
10. Dveksler, G. S., C. W. Diffenbach, C. B. Cardellichio, K. Mccuaig, M. N. Pensiero, G. S. Jiang, N. Beauchemin, and K. V. Holmes. 1993. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus A59. J. Virol. 67:1-8.
11. Dveksler, G. S., M. N. Pensiero, C. W. Diffenbach, C. B. Cardellichio, A. A. Basile, P. E. Elia, and K. V. Holmes. 1993. Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor. Proc. Natl. Acad. Sci. USA 90:1716-1720.
12. Dveksler, G. S., M. N. Pensiero, C. B. Cardellichio, R. K. Williams, G. Jiang, K. V. Holmes, and C. W. Diffenbach. 1991. Cloning of the mouse hepatitis virus (MHV) receptor: Expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:6881-6891.
13. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient expression system based on recombinant vaccinia virus that synthesizes T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
14. Gallagher, T., M. J. Buchmeier, and S. Perlman. 1992. Cell-receptor independent infection by a neurotropic murine coronavirus. Virology 191:517-522.
15. Gallagher, T. M. 1996. Murine coronavirus membrane fusion is blocked by modification of thiols buried within the spike protein. J. Virol. 70:4683-4690.
16. Gallagher, T. M., C. Escarmis, and M. J. Buchmeier. 1991. Alteration of the pH dependence of coronavirus-induced cell fusion: Effect of mutations in the spike glycoprotein. J. Virol. 65:1916-1938.
17. Gilbert, J. M., L. D. Hernandez, J. W. Balliet, P. Bates, and J. M. White. 1995. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein. J. Virol. 69:7410-7415.
18. Hernandez, L. D., R. J. Peters, S. E. Delos, J. A. T. Young, D. A. Agard, and J. M. White. 1997. Activation of a retroviral membrane fusion protein: Soluble receptor-induced liposome binding of the ALSV envelope glycoprotein. J. Cell Biol. 139:1455-1467.
19. Kooi, C., M. Cervin, and R. Anderson. 1991. Differentiation of acid pH-dependent and -nondependent entry pathways for mouse hepatitis virus. Virology 180:108-119.
20. Krueger, D. K., S. M. Kelly, D. N. Lewicki, R. Ruffolo, and T. M. Gallagher. 2001. Variations in disparate regions of the murine coronavirus spike protein impact the initiation of membrane fusion. J. Virol. 75:2792-2802.
21. Kubo, H., Y. K. Yamada, and F. Taguchi. 1994. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J. Virol. 68:5403-5410.
22. Kumanishi, T. 1967. Brain tumors induced with Rous sarcoma virus, Schmidt-Ruppin strain. 1. Induction of brain tumors in adult mice with Rous chicken sarcoma cells. Japan. J. Exp. Med. 37:461-474.
23. Lai, M. M. C., and D. Cavanagh. 1997. The molecular biology of coronaviruses. Adv. Virus Res. 48:1-100.
24. Lewicki, D. N., and T. M. Gallagher. 2002. Quaternary structure of coronavirus spikes in complex with CEACAM cellular receptors. J. Biol. Chem. 277:19727-19734.
25. Lu, M., S. C. Blacklow, and P. S. Kim. 1995. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2:1075-1082.
26. Luo, Z., and S. Weiss. 1998. Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein. Virology 244: 483-494.
27. Luytjes, W., D. Geerts, W. Posthumus, R. Meloen, and W. J. M. Spaan. 1989. Amino acid sequence of a conserved neutralizing epitope of murine coronaviruses. J. Virol. 63:1408-1412.
28. Mallucci, L. 1966. Effect of chloroquine on lysosomes and on growth of mouse hepatitis virus (MHV-3). Virology 28:355-362.
29. Matsuyama, S., and F. Taguchi. 2000. Impaired entry of soluble receptor-resistant mutants of mouse hepatitis virus into cells expressing MHVR2 receptor. Virology 273:80-89.
30. Matsuyama, S., and F. Taguchi. 2002. Combination between S1N330 and a region in S2 of murine coronavirus spike protein is important for virus entry into cells expressing CEACAMlb receptor. Virology 295:160-171.
31. Mizzen, L., A. Hilton, S. Cheley, and R. Anderson. 1985. Attenuation of murine coronavirus infection by ammonium chloride. Virology 142:378-388.
32. Nash, T. C., and M. J. Buchmeier. 1997. Entry of mouse hepatitis virus into cells by endosomal and nonendosomal pathways. Virology 233:1-8.
33. Nedellec, P., G. S. Dveksler, E. Daniels, E. Turbide, B. Chow, A. A. Basile, K. V. Holmes, and N. Beauchemin. 1994. Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses. J. Virol. 68:4525-4537.
34. Ohtsuka, N., Y. K. Yamada, and F. Taguchi. 1996. Difference of virus-binding activity of two receptor proteins for mouse hepatitis virus. J. Gen. Virol. 77:1683-1692.
35. Ohtsuka, N., and T. Taguchi. 1997. Mouse susceptibility to mouse hepatitis virus infection links with viral receptor genotype. J. Virol. 71:8860-8863.
36. Rao, P. V., S. Kumari, and T. M. Gallagher. 1997. Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells. Virology. 229:336-348.
37. Routledge, E., R. Stauber, M. Pfleiderer, and S. G. Siddell. 1991. Analysis of murine coronavirus surface glycoprotein functions by using monoclonal antibodies. J. Virol. 65:254-262.
38. Saeki, K., N. Ohtsuka, and F. Taguchi. 1997. Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants. J. Virol. 71:9024-9031.
39. Sattentau, O. J., and J. P. Moore. 1991. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:407-415.
40. Sodroski, J. G. 1999. HIV-1 entry inhibitors in the side pocket. Cell 99:243-246.
41. Sturman, L. S., C. S. Ricard, and K. V. Holmes. 1985. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: Activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J. Virol. 56:904-911.
42. Suzuki, H., and F. Taguchi. 1996. Analysis of the receptor binding site of murine coronavirus spike glycoprotein. J. Virol. 70:2632-2636.
43. Taguchi, F. 1993. Fusion formation by uncleaved spike protein of murine coronavirus JHMV variant cl-2. J. Virol. 67:1195-1202.
44. Taguchi, F. 1999. Biological functions of mouse hepatitis virus (MHV) spike (S) protein and implication of S protein-MHV receptor interaction in virus virulence. Curr. Top. Virol. 1:245-252.
45. Taguchi, F., T. Ikeda, and H. Shida. 1992. Molecular cloning and expression of a spike protein of neurovirulent murine coronavirus JHMV variant cl-2. J. Gen. Virol. 73:1065-1072.
46. Taguchi, F., and S. Matsuyama. 2002. Soluble receptor potentiates receptor-independent infection by murine coronavirus. J. Virol. 76:950-958.
47. Taguchi, F., S. Matsuyama, and K. Saeki. 1999. Difference in Bgp-independent fusion activity among mouse hepatitis viruses. Arch. Virol. 144:2041-2049.
48. Taguchi, F., and Y. K. Shimazaki. 2000. Functional analysis of an epitope in the S2 subunit of murine coronavirus spike protein: Involvement in fusion activity. J. Gen. Virol. 81:2867-2871.
49. Taguchi, F., S. G. Siddell, H. Wege, and V. ter Meulen. 1985. Characterization of a variant virus selected in rat brain after infection by coronavirus mouse hepatitis virus JHM. J. Virol. 54:429-435.
50. Taguchi, F., A. Yamada, and K. Fujiwara. 1980. Resistance to highly virulent mouse hepatitis virus acquired by mice after low-virulence infection: Enhanced antiviral activity of macrophages. Infect. Immun. 29:42-49.
51. White, J. M. 1990. Viral and cellular membrane fusion proteins. Annu. Rev. Physiol. 52:675-697.
52. Williams, R. K., G. S. Jiang, and K. V. Holmes. 1991. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA 88:5533-5536.
53. Yokomori, K., and M. M. C. Lai. 1992. The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: Implication for the requirement of a second factor for virus infection. J. Virol. 66:6931-6938.